OCRA PR/SG device - Oral Collection Kit (for 5 patients)
OCRA PR/SG device - Oral Collection Kit (for 5 patients) - Image 2
OCRA PR/SG device - Oral Collection Kit (for 5 patients) - Image 3
OCRA PR/SG device - Oral Collection Kit (for 5 patients) - Image 4
OCRA PR/SG device - Oral Collection Kit (for 5 patients) - Image 5
OCRA PR/SG device - Oral Collection Kit (for 5 patients) - Image 6

OCRA PR/SG device – Oral Collection Kit (for 5 patients)

€ 160.00 (excl. VAT)

Kit to collect a sample of the patient’s oral tissue and subsequently assess their oral carcinoma risk score, based on Studium Genetics’ proprietary technology (Oral Carcinoma Risk Algorithm, SG-OCRA™). Sampling kit for 5 patients.

The analysis of the sample is sold separately and is not included in the cost of the kit.

What’s in the box:

  • 5 sterilised brushes with breakpoint, individually packaged.
  • 5 barcoded collection vials containing 400 μL of preservation solution.
  • 5 pre-printed clinical registry forms, to be filled-out by the healthcare professional and kept among her/his confidential records. The clinical form contains sensitive personal data about the patient and should not be shared of mailed.
  • 5 labels in duplicate pre-printed with a pre-generated code (ID), one for the patient registry from and the other to be applied on the collection vial.
  • Instructions for use

For the use of the sampling kit and how to order the actual test, follow the instructions on the Studium Genetics’ website.

All prices are excluding VAT. Studium Genetics’ online shop can only sell to registered businesses in the European Union. As a intra-EU B2B sale Studium Genetics will not collect any VAT. The customer is liable to pay the VAT due according to the rate in their country under the reverse-charge mechanism.

In stock

SKU: SG001-5PR-1 Category:

Description

Studium Genetics has developed and patented the  Oral Carcinoma Risk Algorithm (SG-OCRA™) for the early detection of the Oral Squamous Cells Carcinoma (OSCC) and its precursor, severe displasia. The patented method is based on the quantitative analysis of DNA methylation using bisulfite Next Generation Sequencing (NGS) on exfoliating samples of oral mucosa..

The markers involved in this invention are a set of 13 genes whose methylation pattern aberrations are indicative of  severe displasia and/or OSCC.

The 13 genes’ methylation pattern  is quantitatively analysed using an patented algorithm that computes a risk score. This score will help doctors to identify patients at risk of oral cancer.

The sampling kit and the included preservation solution allows to store the DNA samples at room temperature ensuring the stability of the nucleic acids during storage and shipment.

For the use of the sampling and how to order the test, follow the instructions on the Studium Genetics’ website.

Additional information

Weight 800 g
Dimensions 28 × 10 × 38 cm